AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
ACTIVATION OF LOW AVIDITY CTL SPECIFIC FOR A SELF EPITOPE RESULTS IN TUMOR REJECTION BUT NOT AUTOIMMUNITY
Authors: MORGAN DJ KREUWEL HTC FLECK S LEVITSKY HI PARDOLL DM SHERMAN LA
Citation: Dj. Morgan et al., ACTIVATION OF LOW AVIDITY CTL SPECIFIC FOR A SELF EPITOPE RESULTS IN TUMOR REJECTION BUT NOT AUTOIMMUNITY, The Journal of immunology, 160(2), 1998, pp. 643-651
CHRONIC OXYTOCIN PRETREATMENT INHIBITS ADENYLYL-CYCLASE ACTIVITY IN CULTURED RAT MYOMETRIAL CELLS
Authors: LINDEMAN KS HIRSHMAN CA KUHL JS LEVITSKY HI EMALA CW
Citation: Ks. Lindeman et al., CHRONIC OXYTOCIN PRETREATMENT INHIBITS ADENYLYL-CYCLASE ACTIVITY IN CULTURED RAT MYOMETRIAL CELLS, Biology of reproduction, 59(5), 1998, pp. 1108-1115
CANARYPOX VIRUS VECTORS FOR GENE-TRANSFER IN CANCER-IMMUNOTHERAPY
Authors: LEVITSKY HI
Citation: Hi. Levitsky, CANARYPOX VIRUS VECTORS FOR GENE-TRANSFER IN CANCER-IMMUNOTHERAPY, Journal of the National Cancer Institute, 89(6), 1997, pp. 408-409
ACCESSORIES FOR NAKED DNA VACCINES
Authors: LEVITSKY HI
Citation: Hi. Levitsky, ACCESSORIES FOR NAKED DNA VACCINES, Nature biotechnology, 15(7), 1997, pp. 619-620
THE BEST CYTOKINE FOR THE JOB
Authors: LEVITSKY HI
Citation: Hi. Levitsky, THE BEST CYTOKINE FOR THE JOB, Nature medicine, 3(2), 1997, pp. 126-126
DEVELOPMENT OF IGE-MEDIATED SENSITIZATION TO CONTAMINATING FETAL CALFSERUM-PROTEINS DURING IMMUNIZATION WITH HUMAN RENAL-CARCINOMA VACCINES
Authors: BECK LA SAMPSON H COLUMBO M SIMONS JW JAFFEE EM WEBER C LEVITSKY HI PARDOLL DM MARSHALL FF LEIFERMAN KM BOCHNER BS
Citation: La. Beck et al., DEVELOPMENT OF IGE-MEDIATED SENSITIZATION TO CONTAMINATING FETAL CALFSERUM-PROTEINS DURING IMMUNIZATION WITH HUMAN RENAL-CARCINOMA VACCINES, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1377-1377
PREVIOUS EXPOSURE TO VACCINIA LIMITS THE EFFECT OF AN ANTITUMOR RECOMBINANT VACCINIA
Authors: FEIN S STAVELYOCARROLL K LEVITSKY HI PARDOLL DM WU TC
Citation: S. Fein et al., PREVIOUS EXPOSURE TO VACCINIA LIMITS THE EFFECT OF AN ANTITUMOR RECOMBINANT VACCINIA, Laboratory investigation, 76(1), 1997, pp. 807-807
BIOACTIVITY OF AUTOLOGOUS IRRADIATED RENAL-CELL CARCINOMA VACCINES GENERATED BY EX-VIVO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE-TRANSFER
Authors: SIMONS JW JAFFEE EM WEBER CE LEVITSKY HI NELSON WG CARDUCCI MA LAZENBY AJ COHEN LK FINN CC CLIFT SM HAUDA KM BECK LA LEIFERMAN KM OWENS AH PIANTADOSI S DRANOFF G MULLIGAN RC PARDOLL DM MARSHALL FF
Citation: Jw. Simons et al., BIOACTIVITY OF AUTOLOGOUS IRRADIATED RENAL-CELL CARCINOMA VACCINES GENERATED BY EX-VIVO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE-TRANSFER, Cancer research, 57(8), 1997, pp. 1537-1546
INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE IS AN ENTRY EVENT IN THE COURSE OF LYMPHOMA PROGRESSION - A POTENTIAL BARRIER TO IMMUNE-ENHANCING THERAPEUTIC STRATEGIES
Authors: SOTOMAYOR EM BORRELLO I STAVELEYOCARROLL K MONTGOMERY J FEIN S HWANG L LEVITSKY HI FUCHS E
Citation: Em. Sotomayor et al., INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE IS AN ENTRY EVENT IN THE COURSE OF LYMPHOMA PROGRESSION - A POTENTIAL BARRIER TO IMMUNE-ENHANCING THERAPEUTIC STRATEGIES, Blood, 90(10), 1997, pp. 2034-2034
IN-VIVO CROSS-PRIMING OF MHC CLASS-I - RESTRICTED ANTIGENS REQUIRES THE TAP TRANSPORTER
Authors: HUANG AYC BRUCE AT PARDOLL DM LEVITSKY HI
Citation: Ayc. Huang et al., IN-VIVO CROSS-PRIMING OF MHC CLASS-I - RESTRICTED ANTIGENS REQUIRES THE TAP TRANSPORTER, Immunity, 4(4), 1996, pp. 349-355
ENHANCED IMMUNE PRIMING WITH SPATIAL-DISTRIBUTION OF PARACRINE CYTOKINE VACCINES
Authors: JAFFEE EM THOMAS MC HUANG AYC HAUDA KM LEVITSKY HI PARDOLL DM
Citation: Em. Jaffee et al., ENHANCED IMMUNE PRIMING WITH SPATIAL-DISTRIBUTION OF PARACRINE CYTOKINE VACCINES, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 176-183
ARTERIAL DELIVERY OF GENETICALLY LABELED SKELETAL MYOBLASTS TO THE MURINE HEART - LONG-TERM SURVIVAL AND PHENOTYPIC MODIFICATION OF IMPLANTED MYOBLASTS
Authors: ROBINSON SW CHO PW LEVITSKY HI OLSON JL HRUBAN RH ACKER MA KESSLER PD
Citation: Sw. Robinson et al., ARTERIAL DELIVERY OF GENETICALLY LABELED SKELETAL MYOBLASTS TO THE MURINE HEART - LONG-TERM SURVIVAL AND PHENOTYPIC MODIFICATION OF IMPLANTED MYOBLASTS, Cell transplantation, 5(1), 1996, pp. 77-91
IMMUNIZATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED, BUT NOT B7-1-TRANSDUCED, LYMPHOMA-CELLS PRIMES IDIOTYPE-SPECIFIC T-CELLS AND GENERATES POTENT SYSTEMIC ANTITUMOR IMMUNITY
Authors: LEVITSKY HI MONTGOMERY J AHMADZADEH M STAVELEYOCARROLL K GUARNIERI F LONGO DL KWAK LW
Citation: Hi. Levitsky et al., IMMUNIZATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED, BUT NOT B7-1-TRANSDUCED, LYMPHOMA-CELLS PRIMES IDIOTYPE-SPECIFIC T-CELLS AND GENERATES POTENT SYSTEMIC ANTITUMOR IMMUNITY, The Journal of immunology, 156(10), 1996, pp. 3858-3865
DOES B7-1 EXPRESSION CONFER ANTIGEN-PRESENTING CELL CAPACITY TO TUMORS IN-VIVO
Authors: HUANG AYC BRUCE AT PARDOLL DM LEVITSKY HI
Citation: Ayc. Huang et al., DOES B7-1 EXPRESSION CONFER ANTIGEN-PRESENTING CELL CAPACITY TO TUMORS IN-VIVO, The Journal of experimental medicine, 183(3), 1996, pp. 769-776
TREATMENT OF ESTABLISHED TUMORS WITH A NOVEL VACCINE THAT ENHANCES MAJOR HISTOCOMPATIBILITY CLASS-II PRESENTATION OF TUMOR-ANTIGEN
Authors: LIN KY GUARNIERI FG STAVELEYOCARROLL KF LEVITSKY HI AUGUST JT PARDOLL DM WU TC
Citation: Ky. Lin et al., TREATMENT OF ESTABLISHED TUMORS WITH A NOVEL VACCINE THAT ENHANCES MAJOR HISTOCOMPATIBILITY CLASS-II PRESENTATION OF TUMOR-ANTIGEN, Cancer research, 56(1), 1996, pp. 21-26
USE OF MURINE MODELS OF CYTOKINE-SECRETING TUMOR VACCINES TO STUDY FEASIBILITY AND TOXICITY ISSUES CRITICAL TO DESIGNING CLINICAL-TRIALS
Authors: JAFFEE EM LAZENBY A MEURER J MARSHALL F HAUDA KM COUNTS C HURWITZ H SIMONS JW LEVITSKY HI PARDOLL DM
Citation: Em. Jaffee et al., USE OF MURINE MODELS OF CYTOKINE-SECRETING TUMOR VACCINES TO STUDY FEASIBILITY AND TOXICITY ISSUES CRITICAL TO DESIGNING CLINICAL-TRIALS, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 1-9
PHASE-I STUDY OF NONREPLICATING AUTOLOGOUS TUMOR-CELL INJECTIONS USING CELLS PREPARED WITH OR WITHOUT GM-CSF GENE TRANSDUCTION IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: BERNS AJM CLIFT S COHEN LK DONEHOWER RC DRANOFF G HAUDA KM JAFFEE EM LAZENBY AJ LEVITSKY HI MARSHALL FF MULLIGAN RC NELSON WG OWENS AH PARDOLL DM PARRY G PARTIN AH PIANTADOSI S SIMONS JW ZABORA JR
Citation: Ajm. Berns et al., PHASE-I STUDY OF NONREPLICATING AUTOLOGOUS TUMOR-CELL INJECTIONS USING CELLS PREPARED WITH OR WITHOUT GM-CSF GENE TRANSDUCTION IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Human gene therapy, 6(3), 1995, pp. 347-368
ROLE OF B-CELL TUMOR VS HOST BONE-MARROW-DERIVED APC IN THE PRIMING OF TUMOR-SPECIFIC CTL
Authors: BRUCE AT HUANG AYC PARDOLL DM LEVITSKY HI
Citation: At. Bruce et al., ROLE OF B-CELL TUMOR VS HOST BONE-MARROW-DERIVED APC IN THE PRIMING OF TUMOR-SPECIFIC CTL, Journal of cellular biochemistry, 1995, pp. 89-89
A POTENTIAL IN-VITRO PARAMETER OF IMMUNE PRIMING FOLLOWING VACCINATION WITH A GM-CSF SECRETING TUMOR
Authors: HAUDA KM COUNTS CA WEBER CE LAZENBY AJ MARSHALL FF PARDOLL DM HURWITZ H LEVITSKY HI SIMONS JW NELSON WG CARDUCCI M JAFFEE EM HOPKINS J
Citation: Km. Hauda et al., A POTENTIAL IN-VITRO PARAMETER OF IMMUNE PRIMING FOLLOWING VACCINATION WITH A GM-CSF SECRETING TUMOR, Journal of cellular biochemistry, 1995, pp. 168-168
PRESENTATION OF TUMOR-SPECIFIC ANTIGEN BY B7 EXPRESSING MURINE EPITHELIAL CARCINOMA IN THE PRIMING OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
Authors: HUANG AYC BRUCE AT PARDOLL DM LEVITSKY HI
Citation: Ayc. Huang et al., PRESENTATION OF TUMOR-SPECIFIC ANTIGEN BY B7 EXPRESSING MURINE EPITHELIAL CARCINOMA IN THE PRIMING OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES, Journal of cellular biochemistry, 1995, pp. 169-169
ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PRESENTATION OF ANTIGENS
Authors: WU TC GUARNIERI FG STAVELEYOCARROLL KF VISCIDI RP LEVITSKY HI HEDRICK L CHO KR AUGUST JT PARDOLL DM
Citation: Tc. Wu et al., ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PRESENTATION OF ANTIGENS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(25), 1995, pp. 11671-11675
A REASSESSMENT OF THE ROLE OF B7-1 EXPRESSION IN TUMOR REJECTION
Authors: WU TC HUANG AYC JAFFEE EM LEVITSKY HI PARDOLL DM
Citation: Tc. Wu et al., A REASSESSMENT OF THE ROLE OF B7-1 EXPRESSION IN TUMOR REJECTION, The Journal of experimental medicine, 182(5), 1995, pp. 1415-1421
ANTINEOPLASTIC DRUG AND TUMOR VACCINES - RATIONAL COMBINATION THERAPY
Authors: NIGAM A LEVITSKY HI YACAVONE RF PARDOLL DM NELSON WG
Citation: A. Nigam et al., ANTINEOPLASTIC DRUG AND TUMOR VACCINES - RATIONAL COMBINATION THERAPY, Gastroenterology, 108(4), 1995, pp. 515-515
IMMUNIZATION WITH GM-CSF-TRANSDUCED, BUT NOT B7-1-TRANSDUCED LYMPHOMA-CELLS PRIMES IDIOTYPE - SPECIFIC T-CELLS AND GENERATES POTENT SYSTEMIC ANTITUMOR IMMUNITY
Authors: LEVITSKY HI MONTGOMERY J AHMADZADEH M LONGO DL KWAK LW
Citation: Hi. Levitsky et al., IMMUNIZATION WITH GM-CSF-TRANSDUCED, BUT NOT B7-1-TRANSDUCED LYMPHOMA-CELLS PRIMES IDIOTYPE - SPECIFIC T-CELLS AND GENERATES POTENT SYSTEMIC ANTITUMOR IMMUNITY, Blood, 86(10), 1995, pp. 2399-2399
ENGINEERING A NOVEL INTRACELLULAR PATHWAY FOR MHC CLASS-II PRESENTATION OF ANTIGEN
Authors: STAVELEYOCARROLL KF GUARNIERI FG LEVITSKY HI GOLUMBEK P AUGUST JT PARDOLL DM
Citation: Kf. Staveleyocarroll et al., ENGINEERING A NOVEL INTRACELLULAR PATHWAY FOR MHC CLASS-II PRESENTATION OF ANTIGEN, Journal of cellular biochemistry, 1994, pp. 337-337
Risultati: 1-25 | 26-30